Overview
Clair Health is developing a hormone-tracking product focused on women’s health, positioned against general-purpose wearables that may not capture hormone-driven signals. Its target market is women seeking more specific insight into hormonal patterns than products such as Oura or WHOOP provide. The company disclosed about $12 million in funding, including $11.6 million from Khosla Ventures in an undisclosed round. Led by Jenny Duan, Clair is differentiated by its narrow focus on women’s hormones rather than broad activity or recovery metrics.
Funding History
At 21, Jenny Duan saw what Oura and WHOOP missed: women’s hormones. She raised $11.6M from Khosla Ventures to track them
Frequently Asked Questions
- How much funding does AI Funding track for Clair Health?
- AI Funding tracks $12M for Clair Health across 1 funding round in this database.
- Who are Clair Health's investors?
- Clair Health's investors include Khosla Ventures.
- What does Clair Health do?
- Clair Health is developing a hormone-tracking product focused on women’s health, positioned against general-purpose wearables that may not capture hormone-driven signals. Its target market is women seeking more specific insight into hormonal patterns than products such as Oura or WHOOP provide. The company disclosed about $12 million in funding, including $11.6 million from Khosla Ventures in an undisclosed round. Led by Jenny Duan, Clair is differentiated by its narrow focus on women’s hormones rather than broad activity or recovery metrics.
- Where is Clair Health headquartered?
- Clair Health is headquartered in San Francisco, CA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.